Hyaluronic Acid-based Biodegradable Material Development

Hyaluronic Acid-based Biodegradable Material Development


CD BioGlyco is committed to providing a variety of chemical modification strategies to help clients prepare hyaluronic acid (HA)-based biodegradable materials without affecting the groups involved in biological interactions. Our flexible solutions allow customized high-quality HA derivatives to expand the biomedical applications of HA.

Biomedical Applications of HA

HA is a high molecular weight, non-sulfated anionic polysaccharide composed of N-acetyl-d-glucosamine (GlcNAc) and d-glucuronic acid (GlcA). HA is a multifunctional biomaterial that binds to cell-specific surface markers such as CD44 (often overexpressed on the surface of tumor cells). As one of the main components of the extracellular matrix that exists widely in the human body, HA acts as a signaling molecule for a variety of biological functions, such as leukocyte homing, cell adhesion, growth, and migration.

HA has been widely used in skin regeneration, tissue engineering, drug delivery, and molecular imaging due to its unique hydrodynamic properties, good viscoelasticity and strainability, biocompatibility, biodegradation, non-toxic, non-immunogenic, and non-inflammatory properties. With the expansion of the application scope of hyaluronic acid and the continuous emergence of new medical materials, the research on HA has increased in recent years. Ongoing research on HA and its various modifications testifies to its unarguable share in the advancement of the biomedical field.

Fig.1 Scheme of HA-DOX (doxorubicin) electrostatic complex formation and encapsulation into liposomes. (Tiwari & Bahadur, 2019)Fig.1 Scheme of HA-DOX (doxorubicin) electrostatic complex formation and encapsulation into liposomes. (Tiwari & Bahadur, 2019)

HA-based Biodegradable Material Development Services at CD BioGlyco

Researchers at CD BioGlyco focus on the latest updates in HA research and are working to establish various modification methods. We help clients improve the biological and physicochemical properties of HA to produce a variety of modified HA-based biodegradable materials for biomedical applications. We offer multiple methods such as cross-linking, linking with hydrophobic substances and drugs, and grafting polymers that lead to self-assembly and polyion complexes with cationic species (polymers, surfactants, etc.). Our services include but are not limited to:

In addition, we also provide clients with HA in various physical forms, including:

  • HA viscoelastic solutions
  • HA-based scaffolds
  • HA nanoparticles

Applications of HA in Therapeutics

  • Cancer therapy development
  • Development of vascular, cartilage, bone, and skin tissue engineering
  • Development of wound healing drug

As a leading supplier of Polysaccharide-based Biodegradable Materials, CD BioGlyco provides high-quality HA-based biodegradable materials to many well-known pharmaceutical enterprises, biotechnology companies, and scientific research institutions.

If you are interested in our business, please feel free to contact us for more details, and we will respond promptly.


  1. Tiwari, S.; Bahadur, P. Modified hyaluronic acid-based materials for biomedical applications. International journal of biological macromolecules. 2019, 121: 556-571.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.